LEGN

Legend Biotech (LEGN)

About Legend Biotech (LEGN)

Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.

Details

Daily high
$20.17
Daily low
$19.84
Price at open
$20.02
52 Week High
$38.35
52 Week Low
$16.24
Market cap
3.6B
Dividend yield
0.00%
Volume
343,643
Avg. volume
2.8M
P/E ratio
-14.17

Legend Biotech News

Details

Daily high
$20.17
Daily low
$19.84
Price at open
$20.02
52 Week High
$38.35
52 Week Low
$16.24
Market cap
3.6B
Dividend yield
0.00%
Volume
343,643
Avg. volume
2.8M
P/E ratio
-14.17